Cargando…
Magnetic resonance spectroscopic imaging for detecting metabolic changes in glioblastoma after anti-angiogenic therapy—a systematic literature review
BACKGROUND: The impact of anti-angiogenic therapy (AAT) on patients with glioblastoma (GBM) is unclear due to a disconnect between radiographic findings and overall survivorship. MR spectroscopy (MRS) can provide clinically relevant information regarding tumor metabolism in response to AAT. This rev...
Autores principales: | El-Abtah, Mohamed E, Talati, Pratik, Dietrich, Jorg, Gerstner, Elizabeth R, Ratai, Eva-Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307101/ https://www.ncbi.nlm.nih.gov/pubmed/35892047 http://dx.doi.org/10.1093/noajnl/vdac103 |
Ejemplares similares
-
MR spectroscopic imaging predicts early response to anti-angiogenic therapy in recurrent glioblastoma
por: Talati, Pratik, et al.
Publicado: (2021) -
Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastoma
por: El-Abtah, Mohamed E, et al.
Publicado: (2022) -
Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival
por: Andronesi, Ovidiu C., et al.
Publicado: (2017) -
Delineation of recurrent glioblastoma by whole brain spectroscopic magnetic resonance imaging
por: Bell, Jonathan B., et al.
Publicado: (2023) -
ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy
por: Ratai, Eva-Maria, et al.
Publicado: (2018)